|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
32,633,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,434,166 |
Avg
Vol: |
649,368 |
52
Week Range: |
$21.74 - $21.74 |
|
Level
I Sector: |
Industrials |
Level
II Sector: |
Diversified Services |
Level
III Sector: |
Research Services |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-09-26 |
2024-06-25 |
2023-12-26 |
2022-12-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fine Margalit |
Executive Vice President, API |
|
2017-08-31 |
4 |
D |
$21.75 |
$512,060 |
D/D |
(23,543) |
0 |
|
- |
|
Fine Margalit |
Executive Vice President, API |
|
2017-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,318 |
23,543 |
|
- |
|
Deming David H |
Director |
|
2017-08-31 |
4 |
D |
$21.75 |
$148,727 |
D/D |
(6,838) |
0 |
|
- |
|
D Ambra Thomas E Phd |
Chairman, Board of Directors |
|
2017-08-31 |
4 |
D |
$21.75 |
$52,055,123 |
D/D |
(2,393,339) |
0 |
|
- |
|
Oconnor Kevin |
Director |
|
2017-08-31 |
4 |
D |
$21.75 |
$1,267,481 |
D/D |
(58,275) |
0 |
|
- |
|
Maddaluna Anthony J |
Director |
|
2017-08-31 |
4 |
D |
$21.75 |
$243,818 |
D/D |
(11,210) |
0 |
|
- |
|
Napolitano Fernando |
Director |
|
2017-08-31 |
4 |
D |
$21.75 |
$82,694 |
D/D |
(3,802) |
0 |
|
- |
|
Conway Christopher M. |
SVP, Discovery and Development |
|
2017-08-31 |
4 |
D |
$21.75 |
$1,032,625 |
D/D |
(47,477) |
0 |
|
- |
|
Conway Christopher M. |
SVP, Discovery and Development |
|
2017-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,247 |
47,477 |
|
- |
|
Hagen Steven R |
SVP Manufacturing & Pharmaceut |
|
2017-08-31 |
4 |
D |
$21.75 |
$949,496 |
D/D |
(43,655) |
0 |
|
- |
|
Hagen Steven R |
SVP Manufacturing & Pharmaceut |
|
2017-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,138 |
43,655 |
|
- |
|
Hagen Kenneth Paul |
Director |
|
2017-08-31 |
4 |
D |
$21.75 |
$148,727 |
D/D |
(6,838) |
0 |
|
- |
|
Gutierrez Fuentes Luis Gerardo |
Director |
|
2017-08-31 |
4 |
D |
$21.75 |
$47,850,000 |
I/I |
(2,200,000) |
0 |
|
- |
|
Gutierrez Fuentes Luis Gerardo |
Director |
|
2017-08-31 |
4 |
D |
$21.75 |
$144,768 |
D/D |
(6,656) |
0 |
|
- |
|
D Ambra Thomas E Phd |
Chairman, Board of Directors |
|
2017-08-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
46,200 |
2,393,339 |
|
- |
|
D Ambra Thomas E Phd |
Chairman, Board of Directors |
|
2017-08-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
38,550 |
2,439,539 |
|
- |
|
Fine Margalit |
Executive Vice President, API |
|
2017-07-15 |
4 |
D |
$21.68 |
$32,520 |
D/D |
(1,500) |
11,225 |
|
- |
|
Fine Margalit |
Executive Vice President, API |
|
2017-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
12,725 |
|
- |
|
Boyer Milton |
SVP, Drug Product Manufacturin |
|
2017-07-05 |
4 |
A |
$16.04 |
$16,730 |
D/D |
1,043 |
38,910 |
|
- |
|
Marth William S |
President and CEO |
|
2017-07-05 |
4 |
A |
$16.04 |
$14,179 |
D/D |
884 |
521,888 |
|
- |
|
Svokos George |
Chief Operating Officer |
|
2017-07-05 |
4 |
A |
$16.04 |
$21,237 |
D/D |
1,324 |
123,086 |
|
- |
|
Roth Arthur J |
Director |
|
2017-05-26 |
4 |
OE |
$14.47 |
$72,350 |
D/D |
5,000 |
52,575 |
|
- |
|
Oconnor Kevin |
Director |
|
2017-05-25 |
4 |
OE |
$14.47 |
$72,350 |
D/D |
5,000 |
58,275 |
|
- |
|
Ryan Una S |
Director |
|
2017-05-10 |
4 |
OE |
$14.47 |
$72,350 |
D/D |
5,000 |
51,845 |
|
- |
|
Hagen Steven R |
SVP Manufacturing & Pharmaceut |
|
2017-03-02 |
4 |
D |
$14.52 |
$5,082 |
D/D |
(350) |
40,517 |
|
- |
|
229 Records found
|
|
Page 1 of 10 |
|
|